Tg Therapeutics (TGTX) Finished Goods (2023 - 2025)

Tg Therapeutics' Finished Goods history runs 3 years deep, the most recent figure standing at $21.1 million for Q3 2025.

• In Q3 2025, Finished Goods rose 164.86% year-over-year to $21.1 million; the TTM figure through Sep 2025 stood at $21.1 million (up 164.86% YoY), while the FY2024 annual figure was $13.9 million, up 597.25% from the prior year.
• Finished Goods was $21.1 million for Q3 2025 at Tg Therapeutics, down from $21.8 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $21.8 million in Q2 2025 to a low of $52000.0 in Q1 2023.
• Historically, Finished Goods has averaged $7.5 million across 3 years, with a median of $2.0 million in 2023.
• Biggest YoY gain for Finished Goods was 3559.62% in 2024; the steepest drop was 145.07% in 2024.
• A 3-year view of Finished Goods shows it stood at $2.0 million in 2023, then jumped by 597.25% to $13.9 million in 2024, then soared by 51.3% to $21.1 million in 2025.
• The last three Finished Goods figures came in at $21.1 million (Q3 2025), $21.8 million (Q2 2025), and $10.7 million (Q1 2025), per Business Quant data.